Fiserv's shares dropped over 40% after missing earnings targets, lowering its revenue and profit forecasts, and announcing leadership changes and a move back to Nasdaq to recover from a significant decline.
Lululemon's stock dropped 18% after cutting its full-year guidance due to tariffs and weak U.S. sales, despite beating earnings estimates; analysts warn the situation may worsen as international sales temporarily offset U.S. struggles, but overall growth prospects are challenged by increased competition and market headwinds.
Wendy's stock rose nearly 2% despite lowering its 2025 sales and earnings guidance due to economic challenges, though its Q2 earnings exceeded estimates. The company's stock has declined significantly year-to-date and over the past year, with analysts maintaining a hold rating and a potential upside based on current price targets.
Novo Nordisk is set to report its Q2 earnings after a significant share price decline following a lowered full-year guidance, amid challenges like falling sales of Wegovy and a leadership change, with investors seeking reassurance on regulatory issues and market share loss to Eli Lilly.
Novo Nordisk's stock dropped over 21% after a second guidance cut due to disappointing U.S. sales and increased competition in obesity treatments, raising questions about its future prospects. Despite recent setbacks, the company's international growth and technological advantages suggest the stock may be undervalued, with potential for significant long-term gains for risk-tolerant investors.
Cisco Systems reported better-than-expected fiscal second-quarter results but reduced its full-year guidance and announced plans to cut about 5% of its workforce, or more than 4,000 employees, due to concerns about demand. CEO Chuck Robbins cited caution and scrutiny of deals amid high uncertainty in the macro-environment. The company also mentioned slowing demand, ongoing inventory correction, and weak demand from telco and cable service provider customers. The news led to a negative reaction from Wall Street analysts, with concerns about the company's performance and the impact of the layoffs.
Thermo Fisher Scientific, a major player in the medical equipment industry, has lowered its 2023 outlook for the second time this year due to challenges in the macro environment. The company now expects lower earnings per share and sales than previously projected. This guidance cut suggests that Thermo Fisher may miss Wall Street's fourth-quarter expectations. The stock slumped by 5.5% as a result. Despite the challenges, Thermo Fisher's adjusted earnings for the third quarter exceeded analysts' forecasts, but sales were slightly below expectations. The company attributes the guidance cut to the impact of its COVID-19 business, including a decline in sales of COVID tests. However, analysts believe that the underlying organic growth is in line with peers and that the recent underperformance of the stock may be overdone.
American Airlines and Spirit have both cut their guidance, causing airline stocks to fall once again. This adds to the ongoing turbulence in the sector.
Foot Locker reported falling sales for another quarter and slashed its outlook for the second time this year, blaming "consumer softness" as inflation-weary customers hesitate to spend on footwear and apparel. The company's adjusted Q2 earnings were in line with expectations, but sales fell short and margins were impacted by promotions and higher shrink. Shares plunged 26% in pre-market trading. Foot Locker now expects sales to drop 8% to 9% for the year and cut its adjusted earnings guidance. The retailer has been relying on promotions to drive sales as its lower to middle-income customer base pulls back on discretionary spending. Comparable-store sales dropped 9.4% due to ongoing consumer softness and changes in vendor mix.
Volkswagen Group reported a 48% increase in electric vehicle (EV) deliveries in the first half of 2023, with EVs accounting for 7.4% of total deliveries. The growth was driven by a strong performance in China, where VW has struggled in the past. However, the company has lowered its overall delivery guidance due to logistics bottlenecks. Despite this, VW expects a higher proportion of EV sales in the second half of the year and confirmed its financial outlook for the year.
Despite an analyst's recommendation to stop selling UPS stock, investors are continuing to do so after the logistics company reported first-quarter numbers that met Wall Street expectations but warned that the year was trending toward the low end of sales and profit-margin guidance, effectively cutting guidance.